ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.
한글목차
합성 카나비노이드 시장 규모는 향후 몇 년 동안 연평균 17.9%의 성장률(CAGR)로 2029년까지 43억 달러에 달할 것으로 예상됩니다. 예측 기간 동안의 성장은 디자이너 마약의 인기 증가, 대마초 합법화, 합성 마약에 대한 온라인 접근성 증가, Vape의 인기 증가, 대마초 제품의 커스터마이징 증가 등 여러 가지 요인에 기인하는 것으로 보입니다. 이 기간의 주요 동향으로는 첨단 법의학 독성학 기술, 화학적 패턴 인식을 위한 기계 학습, 클라우드 기반 불법 약물 추적, 합성 카나비노이드 제제의 혁신, 새로운 카나비노이드 유사체 개발 등이 있습니다.
신경 질환 치료에 대한 수요 증가는 합성 카나비노이드 시장의 성장을 견인할 것으로 예상됩니다. 뇌, 척수, 신경에 영향을 미치는 신경 질환은 운동, 감각, 인지, 신체 기능 전반에 영향을 미칠 수 있습니다. 신경질환의 증가는 뇌의 자연적인 노화와 축적된 세포 손상으로 인해 알츠하이머병과 같은 질병이 노화와 함께 만연하기 때문에 세계 인구의 고령화가 주요 원인으로 작용하고 있습니다. 합성 카나비노이드는 뇌의 카나비노이드 수용체와 상호 작용하여 신경전달물질의 활동을 조절하고 신경질환과 관련된 증상을 완화하는 데 도움을 줄 수 있습니다. 예를 들어, 2024년 9월 벨기에에 본부를 둔 유럽뇌위원회(European Brain Council)는 유럽에서 현재 700만 명이 알츠하이머병과 싸우고 있다고 보고했습니다. 이 숫자는 고령화로 인해 2030년까지 2배인 1,400만 명으로 증가할 것으로 예상되며, 전 세계적으로 공중보건의 심각한 문제로 대두되고 있습니다. 이에 따라 신경 질환 치료에 대한 수요 증가가 합성 카나비노이드 시장의 성장을 주도하고 있습니다.
합성 카나비노이드 시장의 주요 기업들은 생산 효율성 향상과 비용 절감을 위해 곰팡이 발현 시스템과 같은 첨단 기술 개발에 주력하고 있습니다. 진균 발현 시스템은 합성 카나비노이드를 생합성하는 유전자 조작 진균을 포함하며, 기존의 화학적 합성이나 식물 추출에 대한 지속가능하고 확장 가능한 대안을 제공합니다. 이러한 시스템을 통해 제약 및 연구용 고순도 카나비노이드의 생산이 가능해집니다. 예를 들어, 2022년 1월 미국 생명공학 기업 Dyadic International Inc.는 합성 카나비노이드 생산을 위한 C1 세포 단백질 생산 플랫폼을 발표했습니다. 이 혁신적인 접근 방식은 칸나비디올(CBD) 및 그 전구체와 같은 카나비노이드를 보다 비용 효율적이고 지속가능한 방식으로 생산하기 위해 사상균의 세포 공장을 이용하는 것입니다. 이 공정은 환경 친화적이고, 에너지 효율적이며, 규제 기준을 충족하는 순도 높은 카나비노이드를 생산할 수 있으며, 만성 통증, 염증 및 기타 질병을 치료하는 데 사용될 수 있습니다.
목차
제1장 주요 요약
제2장 시장 특징
제3장 시장 동향과 전략
제4장 시장 - 금리, 인플레이션, 지정학, 무역 전쟁과 관세, 그리고 코로나와 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오
제5장 세계의 성장 분석과 전략 분석 프레임워크
세계 합성 카나비노이드 PESTEL 분석(정치, 사회, 기술, 환경, 법적 요인, 촉진요인과 억제요인)
최종 이용 산업 분석
세계의 합성 카나비노이드 시장 : 성장률 분석
세계의 합성 카나비노이드 시장 실적 : 규모와 성장, 2019-2024
세계의 합성 카나비노이드 시장 예측 : 규모와 성장, 2024-2029, 2034F
세계 합성 카나비노이드 전체 시장(TAM)
제6장 시장 세분화
세계의 합성 카나비노이드 시장 : 제품 유형별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
고순도 합성 카나비노이드
초순수 합성 카나비노이드
세계의 합성 카나비노이드 시장 처방별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
오일
캡슐
식용
베이프
국소용약
세계의 합성 카나비노이드 시장 : 적응증별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
통증 관리
메스꺼움 또는 구토
신경질환 관리
기타 적응증
세계의 합성 카나비노이드 시장 : 유통 채널별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
병원 약국
소매 약국
온라인 약국
세계의 합성 카나비노이드 시장 : 용도별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
의약품
조사
레크리에이션 이용
농업
식이보충제
세계의 합성 카나비노이드 시장 고순도 합성 카나비노이드 종류별 하위 세분화, 실적과 예측, 2019-2024, 2024-2029F, 2034F
의약품 등급 카나비노이드
연구 등급 카나비노이드
산업용 카나비노이드
세계의 합성 카나비노이드 시장초순수 합성 카나비노이드 종류별 하위 세분화, 실적과 예측, 2019-2024, 2024-2029F, 2034F
의료 등급 카나비노이드
바이오테크놀러지 등급 카나비노이드
분석 표준 카나비노이드
제7장 지역별·국가별 분석
세계의 합성 카나비노이드 시장 : 지역별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
세계의 합성 카나비노이드 시장 : 국가별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
제8장 아시아태평양 시장
제9장 중국 시장
제10장 인도 시장
제11장 일본 시장
제12장 호주 시장
제13장 인도네시아 시장
제14장 한국 시장
제15장 서유럽 시장
제16장 영국 시장
제17장 독일 시장
제18장 프랑스 시장
제19장 이탈리아 시장
제20장 스페인 시장
제21장 동유럽 시장
제22장 러시아 시장
제23장 북미 시장
제24장 미국 시장
제25장 캐나다 시장
제26장 남미 시장
제27장 브라질 시장
제28장 중동 시장
제29장 아프리카 시장
제30장 경쟁 구도와 기업 개요
합성 카나비노이드 시장 : 경쟁 구도
합성 카나비노이드 시장 : 기업 개요
Johnson Matthey Overview, Products and Services, Strategy and Financial Analysis
Harmony Biosciences Overview, Products and Services, Strategy and Financial Analysis
BioVectra Overview, Products and Services, Strategy and Financial Analysis
Restek Corporation Overview, Products and Services, Strategy and Financial Analysis
Noramco Inc. Overview, Products and Services, Strategy and Financial Analysis
제31장 기타 주요 기업과 혁신적 기업
Cayman Chemical
Cerilliant Corporation
Skye Bioscience
Purisys LLC
Chiron AS
Lygos Inc.
Botanix Pharmaceuticals
CB Therapeutics Inc.
BayMedica
Zynerba Pharmaceuticals Inc.
Kannalife Sciences Inc.
SciSparc Ltd.
31.14. Tetra Bio-Pharma Inc
31.15. Canntab Therapeutics Ltd
제32장 세계의 시장 경쟁 벤치마킹과 대시보드
제33장 주요 인수합병
제34장 최근의 시장 동향
제35장 시장 잠재력이 높은 국가, 부문, 전략
합성 카나비노이드 시장 2029 : 새로운 기회를 제공하는 국가
합성 카나비노이드 시장 2029 : 새로운 기회를 제공하는 부문
합성 카나비노이드 시장 2029 : 성장 전략
시장 동향에 기반한 전략
경쟁 전략
제36장 부록
ksm
영문 목차
영문목차
Synthetic cannabinoids are laboratory-engineered compounds designed to replicate the effects of natural cannabinoids by binding to cannabinoid receptors in the body. These compounds are produced through advanced chemical synthesis and can be much more potent and unpredictable than their natural counterparts. Some synthetic cannabinoids are also used in regulated pharmaceutical applications for therapeutic purposes.
Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.
The main types of synthetic cannabinoids include high-pure synthetic cannabinoids and ultra-pure synthetic cannabinoids. High-pure synthetic cannabinoids are chemically engineered compounds that replicate the effects of natural cannabinoids, such as tetrahydrocannabinol (THC), found in the cannabis plant. These cannabinoids are available in various formulations, including oils, capsules, edibles, vapes, and topicals, and are used for several indications, such as pain management, nausea and vomiting relief, and the treatment of neurological disorders. They are distributed through different channels, including hospital pharmacies, retail pharmacies, and online pharmacies, and are used in applications such as pharmaceuticals, research, recreational use, agriculture, and nutraceuticals.
The synthetic cannabinoids market research report is one of a series of new reports from The Business Research Company that provides synthetic cannabinoids market statistics, including synthetic cannabinoids industry global market size, regional shares, competitors with a synthetic cannabinoids market share, detailed synthetic cannabinoids market segments, market trends and opportunities, and any further data you may need to thrive in the synthetic cannabinoids industry. This synthetic cannabinoids market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The synthetic cannabinoids market size has grown rapidly in recent years. It will grow from$1.88 billion in 2024 to $2.22 billion in 2025 at a compound annual growth rate (CAGR) of 18.3%. The growth during the historic period can be attributed to several factors, including the rising demand for alternative drugs, an increasing number of cannabis users, expanding pharmaceutical applications, growing demand for legal highs, and a shift towards self-medication.
The synthetic cannabinoids market size is expected to see rapid growth in the next few years. It will grow to$4.30 billion in 2029 at a compound annual growth rate (CAGR) of 17.9%. The growth during the forecast period can be attributed to several factors, including the rising popularity of designer drugs, the growing legalization of cannabis, increased online accessibility of synthetic drugs, the growing popularity of vaping, and the rising customization of cannabinoid products. Key trends during this period include advanced forensic toxicology techniques, machine learning for chemical pattern recognition, cloud-based illicit drug tracking, innovations in synthetic cannabinoid formulations, and the development of novel cannabinoid analogs.
The growing demand for treatments of neurological disorders is expected to drive the expansion of the synthetic cannabinoids market. Neurological disorders, which affect the brain, spinal cord, and nerves, can disrupt movement, sensation, cognition, and overall bodily functions. The rise in neurological conditions is largely attributed to the aging global population, as diseases such as Alzheimer's become more prevalent with age, due to the natural aging of the brain and accumulated cellular damage. Synthetic cannabinoids work by interacting with cannabinoid receptors in the brain, which helps regulate neurotransmitter activity and may assist in alleviating symptoms related to neurological disorders. For example, in September 2024, the European Brain Council, based in Belgium, reported that 7 million people in Europe are currently living with Alzheimer's disease. This number is expected to double to 14 million by 2030, due to the aging population, posing a significant global public health issue. As a result, the increasing demand for treatments for neurological disorders is driving the growth of the synthetic cannabinoids market.
Leading companies in the synthetic cannabinoids market are focusing on developing advanced technologies, such as fungal expression systems, to improve production efficiency and reduce costs. Fungal expression systems involve genetically engineered fungi that biosynthesize synthetic cannabinoids, offering a sustainable and scalable alternative to traditional chemical synthesis or plant extraction methods. These systems enable the production of high-purity cannabinoids for pharmaceutical and research applications. For example, in January 2022, Dyadic International Inc., a biotechnology company based in the US, introduced its C1-cell protein production platform to manufacture synthetic cannabinoids. This innovative approach utilizes filamentous fungal cell factories to produce cannabinoids such as cannabidiol (CBD) and its precursors in a more cost-effective and sustainable manner. The process is environmentally friendly, energy-efficient, and capable of yielding purer cannabinoids that meet regulatory standards, with potential therapeutic uses in treating chronic pain, inflammation, and other medical conditions.
In January 2022, Dermapharm Holding SE, a Germany-based pharmaceutical manufacturer, acquired C3 Cannabinoid Compound Company GmbH for $87.35 million. With this acquisition, Dermapharm Holding SE aims to bolster its position as a leader in the medical cannabis market, expand into new European regions, and leverage synergies to improve patient access while driving growth in cannabinoid-based pharmaceuticals. C3 Cannabinoid Compound Company GmbH, based in Germany, specializes in the production of synthetic cannabinoids.
Major players in the synthetic cannabinoids market are Johnson Matthey, Harmony Biosciences, BioVectra, Restek Corporation, Noramco Inc., Cayman Chemical, Cerilliant Corporation, Skye Bioscience, Purisys LLC, Chiron AS, Lygos Inc., Botanix Pharmaceuticals, CB Therapeutics Inc., BayMedica, Zynerba Pharmaceuticals Inc., Kannalife Sciences Inc., SciSparc Ltd., 180 Life Science, Tetra Bio-Pharma Inc., and Canntab Therapeutics Ltd.
North America was the largest region in the synthetic cannabinoids market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in synthetic cannabinoids report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
The countries covered in the synthetic cannabinoids market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The synthetic cannabinoids market consists of sales of research chemicals, prescription medications, and herbal incense products. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Synthetic Cannabinoids Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on synthetic cannabinoids market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for synthetic cannabinoids ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The synthetic cannabinoids market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:
The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.
Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: PDF, Word and Excel Data Dashboard.
Table of Contents
1. Executive Summary
2. Synthetic Cannabinoids Market Characteristics
3. Synthetic Cannabinoids Market Trends And Strategies
4. Synthetic Cannabinoids Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market
5. Global Synthetic Cannabinoids Growth Analysis And Strategic Analysis Framework
5.1. Global Synthetic Cannabinoids PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
5.2. Analysis Of End Use Industries
5.3. Global Synthetic Cannabinoids Market Growth Rate Analysis
5.4. Global Synthetic Cannabinoids Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
5.5. Global Synthetic Cannabinoids Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
5.6. Global Synthetic Cannabinoids Total Addressable Market (TAM)
6. Synthetic Cannabinoids Market Segmentation
6.1. Global Synthetic Cannabinoids Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
High-Pure Synthetic Cannabinoids
Ultra-Pure Synthetic Cannabinoids
6.2. Global Synthetic Cannabinoids Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Oil
Capsules
Edibles
Vapes
Topicals
6.3. Global Synthetic Cannabinoids Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Pain Management
Nausea Or Vomiting
Neurological Disorder Management
Other Indications
6.4. Global Synthetic Cannabinoids Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
6.5. Global Synthetic Cannabinoids Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Pharmaceuticals
Research
Recreational Use
Agriculture
Nutraceuticals
6.6. Global Synthetic Cannabinoids Market, Sub-Segmentation Of High-Pure Synthetic Cannabinoids, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Pharmaceutical-Grade Cannabinoids
Research-Grade Cannabinoids
Industrial-Use Cannabinoids
6.7. Global Synthetic Cannabinoids Market, Sub-Segmentation Of Ultra-Pure Synthetic Cannabinoids, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Medical-Grade Cannabinoids
Biotechnology-Grade Cannabinoids
Analytical-Standard Cannabinoids
7. Synthetic Cannabinoids Market Regional And Country Analysis
7.1. Global Synthetic Cannabinoids Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
7.2. Global Synthetic Cannabinoids Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
